MDGL
Price
$534.49
Change
+$1.37 (+0.26%)
Updated
Sep 11 closing price
Capitalization
12.34B
47 days until earnings call
Intraday BUY SELL Signals
NXTI
Price
$35.93
Change
+$0.43 (+1.21%)
Updated
Sep 11 closing price
Net Assets
40.82M
Intraday BUY SELL Signals
Interact to see
Advertisement

MDGL vs NXTI

MDGL vs NXTI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MDGL vs. NXTI commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDGL is a StrongBuy and NXTI is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
16
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MDGLNXTI
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
59%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
62%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 17 days ago
77%
Bullish Trend 17 days ago
88%
Declines
ODDS (%)
Bearish Trend 5 days ago
80%
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
89%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (MDGL: $534.49)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDGL’s FA Score shows that 1 FA rating(s) are green while .

  • MDGL’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDGL’s TA Score shows that 5 TA indicator(s) are bullish.

  • MDGL’s TA Score: 5 bullish, 3 bearish.

Price Growth

MDGL (@Biotechnology) experienced а -1.22% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

MDGL is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
MDGL
Daily Signal:
Gain/Loss:
NXTI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BJ91.491.84
+2.05%
BJs Wholesale Club Holdings
TLPH1.24N/A
N/A
Talphera
OYSEU10.45N/A
N/A
Oyster Enterprises II Acquisition Corp
NGL17.58-0.09
-0.51%
NGL Energy Partners LP
FENC10.96-0.34
-3.01%
Fennec Pharmaceuticals

NXTI and

Correlation & Price change

A.I.dvisor tells us that NXTI and KMB have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NXTI and KMB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXTI
1D Price
Change %
NXTI100%
+1.20%
KMB - NXTI
21%
Poorly correlated
-0.34%
ORLY - NXTI
16%
Poorly correlated
+0.36%
MDGL - NXTI
15%
Poorly correlated
+0.26%
HIG - NXTI
14%
Poorly correlated
-0.32%
HSIC - NXTI
12%
Poorly correlated
+1.21%
More